Home › Funds › BNY Mellon › BNY Mellon Emerging Markets Equity ETF
Fund family: BNY Mellon · Filed by BNY Mellon ETF Trust (CIK 1493580) · SEC series S000067264
Ticker: BKEM (C000216366)
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 26,492 with, 13 against, 4 abstentions (not counted as with management); 52 items carried no recommendation; 7 split votes are in neither count. Shareholder proposals: 740 FOR, 52 AGAINST, 0 abstained, by the filing’s own vote-source field.
The same two figures as BNY Mellon’s manager page (141,760 ballot items across 60 funds and accounts), counted the same way for this fund.
| 2025-2026 | This fund | Items | BNY Mellon | Items |
|---|---|---|---|---|
| Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters) | 90.6% | 16,834 | 93.1% | 117,600 |
| Backed environmental and social shareholder proposals at US companies | n/a | 0 | 1.8% | 1,473 |
Each ballot item this fund voted is set against the votes of the other BNY Mellon funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.
Voted differently from most BNY Mellon funds on 16 items (10.4% of the 154 items where a comparison was possible).
| Company | Meeting | Item | This fund | Most BNY Mellon funds | Mgmt | Result |
|---|---|---|---|---|---|---|
| PDD Holdings Inc. | 2025-12-19 | Elect Director Haifeng Lin | Against | FOR — 4 of 4 BNY Mellon funds | Against | — |
| PDD Holdings Inc. | 2025-12-19 | Elect Director Jiazhen Zhao | Against | FOR — 4 of 4 BNY Mellon funds | Against | — |
| PDD Holdings Inc. | 2025-12-19 | Elect Director Lei Chen | Against | FOR — 4 of 4 BNY Mellon funds | Against | — |
| Contemporary Amperex Technology Co., Ltd. | 2026-04-03 | Approve Entrusted Wealth Management Plan | For | AGAINST — 4 of 4 BNY Mellon funds | For | — |
| NetEase, Inc. | 2026-06-23 | Adopt Consultant Sublimit | For | AGAINST — 3 of 3 BNY Mellon funds | For | — |
| NetEase, Inc. | 2026-06-23 | Amend Existing Memorandum and Articles of Association by Adopting the Proposed Third Amended and Restated Memorandum and Articles of Association | For | AGAINST — 3 of 3 BNY Mellon funds | For | — |
| NetEase, Inc. | 2026-06-23 | Amend and Restate the Amended and Restated 2019 Share Incentive Plan as the Second Amended and Restated 2019 Share Incentive Plan | For | AGAINST — 3 of 3 BNY Mellon funds | For | — |
| NetEase, Inc. | 2026-06-23 | Approve Issuance of Equity or Equity-Linked Securities without Preemptive Rights | For | AGAINST — 3 of 3 BNY Mellon funds | For | — |
| NetEase, Inc. | 2026-06-23 | Elect Grace Hui Tang as Director | For | AGAINST — 3 of 3 BNY Mellon funds | For | — |
| Eurobank SA | 2026-04-28 | Amend Remuneration Policy | For | AGAINST — 3 of 3 BNY Mellon funds | For | — |
| Eurobank SA | 2026-04-28 | Approve Share Distribution Plan | For | AGAINST — 3 of 3 BNY Mellon funds | For | — |
| Eurobank SA | 2026-04-28 | Fix Maximum Variable Compensation Ratio for Executives of the Company | For | AGAINST — 3 of 3 BNY Mellon funds | For | — |
| Shenzhen Mindray Bio-Medical Electronics Co., Ltd. | 2026-05-19 | Approve to Appoint Auditor | For | AGAINST — 3 of 3 BNY Mellon funds | For | — |
| Shenzhen Mindray Bio-Medical Electronics Co., Ltd. | 2026-05-19 | Elect Xu Jing as Director | For | AGAINST — 3 of 3 BNY Mellon funds | For | — |
| Tencent Holdings Limited | 2026-05-13 | Approve Issuance of Equity or Equity-Linked Securities without Preemptive Rights | Against | FOR — 3 of 3 BNY Mellon funds | Against | — |
| Tencent Holdings Limited | 2026-05-13 | Approve PricewaterhouseCoopers as Auditors and Authorize Board to Fix Their Remuneration | For | AGAINST — 3 of 3 BNY Mellon funds | For | — |
Download all 16 differences (CSV)
| Proposal type | Items | Against management |
|---|---|---|
| Corporate Governance | 8,763 | 9 |
| Capital Structure | 6,215 | 0 |
| Director Elections | 5,885 | 3 |
| Compensation | 3,133 | 1 |
| Audit-related | 1,385 | 0 |
| Extraordinary Transactions | 907 | 0 |
| Other | 152 | 0 |
| Other Social Issues | 98 | 0 |
| Investment Company Matters | 16 | 0 |
| Shareholder Rights and Defenses | 11 | 0 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| PDD Holdings Inc. | December 19, 2025 | $355,322 | 6 | 0 |
| Tencent Music Entertainment Group | June 30, 2026 | $32,819 | 2 | 0 |
| Vista Energy SAB de CV | April 28, 2026 | $28,467 | 9 | 0 |
| Kanzhun Limited | June 25, 2026 | $25,948 | 10 | 0 |
| Vista Energy SAB de CV | January 27, 2026 | $25,471 | 4 | 0 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| March 31, 2026 | COWAY Co., Ltd. | Elect Park Yoo-gyeong as Outside Director to Serve as an Audit Committee Member (Shareholder Proposal) Shareholder proposal | Against | For |
| March 31, 2026 | COWAY Co., Ltd. | Amend Articles of Incorporation (Audit Committee) (Shareholder Proposal) Shareholder proposal | Against | For |
| March 31, 2026 | LG Chem Ltd. | Amend Articles of Incorporation (Advisory Shareholder Resolutions) (Shareholder Proposal) Shareholder proposal | For | Against |
| March 31, 2026 | LG Chem Ltd. | Amend Articles of Incorporation (Lead Independent Director) (Shareholder Proposal) Shareholder proposal | For | Against |
| March 26, 2026 | BNK Financial Group, Inc. | Approve Total Remuneration of Inside Directors and Outside Directors (Shareholder Proposal) Shareholder proposal | Against | For |
| March 26, 2026 | BNK Financial Group, Inc. | Approve Restricted Stock Unit Grant Details (Shareholder Proposal) Shareholder proposal | Against | For |
26,568 ballot items at 3,289 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, BNY Mellon Emerging Markets Equity ETF (BKEM) voted at 3,289 shareholder meetings of 1,532 companies, on 26,568 ballot items in all. Where management made a recommendation, the fund followed it on 99.9% of the items and voted against it 13 times. Its most frequent area of disagreement was corporate governance (9 of its votes against management). It voted FOR 93.4% of the 792 shareholder proposals on which it cast a FOR or AGAINST vote. It voted FOR the board's own proposals less often than BNY Mellon's funds as a whole (90.6% against 93.1%). It voted differently from most BNY Mellon funds on 16 items.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of BNY Mellon’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.